HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Ginsburg, G. S. Articles by Newby, L. K. Search for Related Content PubMed PubMed Citation Articles by Ginsburg, G. S. Articles by Newby, L. K.

Prospects for Personalized Cardiovascular Medicine

The Impact of Genomics

Geoffrey S. Ginsburg, MD, PhD, FACC^_*,,,_*, Mark P. Donahue, MD, MHS^_*, and L. Kristin Newby, MD, MHS, FACC^_*,

^_* Division of Cardiovascular Medicine, Department of Medicine, Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina.
Duke Clinical Research Institute, Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina.
Center for Genomic Medicine, Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina.

View larger version (27K): [in a new window]   Figure 1 Clinico-genomic biosignatures to predict health, disease, and environmental/drug response. Data from a variety of sources will be integrated to develop patterns of information and models for disease prediction and drug response (5). SNPs = single nucleotide polymorphisms.